|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 567 SEK | +0.89% |
|
+5.98% | +5.39% |
| May. 08 | Transcript : Camurus AB, Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Camurus AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Camurus announced that Alberto Pedroncelli has been appointed new Chief Medical Officer company. He will replace Peter Hjelmström who is leaving the company for other engagements. Pedroncelli comes from a position as Head of Clinical Development & Medical Affairs, Global Endocrinology at Italian company Recordat.
Previousl he worked at Swiss pharmaceutical company Novartis. He will assume his new position on 1 June 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.39% | 2.99B | |
| +31.37% | 588B | |
| -3.22% | 364B | |
| +19.41% | 326B | |
| +5.23% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.34% | 167B | |
| +0.00% | 161B |
CAMURUS AB 